Tianyu Biotech announced that on December 30, 2025, Shi Dongwei, a shareholder holding more than 5% of the shares, released the pledge of 6 million shares, accounting for 18.55% of its holdings and 2.07% of the company's total share capital. On the same day, this portion of the shares was re-pledged. The pledge expires on December 23, 2026, and the financing is used to supplement working capital. Shi Dongwei held 32.3388 million shares of the company, accounting for 11.15% of the total share capital. After the pledge was lifted and re-pledged, he pledged a total of 29 million shares, accounting for 89.68% of his shareholding volume and 9.99% of the company's total share capital. Furthermore, due to a contractual dispute, its holding of 3.181,900 shares was judicially frozen.

Tianyu Biotech announced that on December 30, 2025, Shi Dongwei, a shareholder holding more than 5% of the shares, released the pledge of 6 million shares, accounting for 18.55% of its holdings and 2.07% of the company's total share capital. On the same day, this portion of the shares was re-pledged. The pledge expires on December 23, 2026, and the financing is used to supplement working capital. Shi Dongwei held 32.3388 million shares of the company, accounting for 11.15% of the total share capital. After the pledge was lifted and re-pledged, he pledged a total of 29 million shares, accounting for 89.68% of his shareholding volume and 9.99% of the company's total share capital. Furthermore, due to a contractual dispute, its holding of 3.181,900 shares was judicially frozen.